Identification of Burkholderia cepacia complex pathogens by rapid-cycle PCR with fluorescent hybridization probes
- PMID: 16687590
- DOI: 10.1099/jmm.0.46457-0
Identification of Burkholderia cepacia complex pathogens by rapid-cycle PCR with fluorescent hybridization probes
Abstract
Members of the Burkholderia cepacia complex are important bacterial pathogens in cystic fibrosis (CF) patients. The B. cepacia complex currently consists of nine genetic subgroups (genomovars) of different epidemiological relevance and possibly of different pathogenic potential in humans. In this study, a new approach was developed for the rapid identification of B. cepacia genomovar I, Burkholderia multivorans (genomovar II), Burkholderia cenocepacia (lineage III-A and III-B), Burkholderia stabilis (genomovar IV) and Burkholderia vietnamiensis (genomovar V), which cause the large majority of infections in CF patients. The method was based on the detection of differences in the recA gene sequence by using rapid-cycle PCR and genomovar-specific fluorescence resonance energy transfer (FRET) probes. The genomovar status of all 39 B. cepacia complex strains tested (genomovars I-V) was identified by melting-curve analysis. Each FRET probe produced a specific fluorescence signal only with the respective genomovar, and not with other B. cepacia complex strains and Burkholderia spp. The identification system was easy to handle and revealed B. cepacia complex genomovar I-V status from culture isolates within about 1 h.
Similar articles
-
DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.J Clin Microbiol. 2000 Sep;38(9):3165-73. doi: 10.1128/JCM.38.9.3165-3173.2000. J Clin Microbiol. 2000. PMID: 10970351 Free PMC article.
-
Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex.J Med Microbiol. 2002 Nov;51(11):937-940. doi: 10.1099/0022-1317-51-11-937. J Med Microbiol. 2002. PMID: 12448677
-
PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.J Clin Microbiol. 2001 Dec;39(12):4247-55. doi: 10.1128/JCM.39.12.4247-4255.2001. J Clin Microbiol. 2001. PMID: 11724828 Free PMC article.
-
[Epidemiology of infections associated to "Burkholderia cepacia complex" in the course of cystic fibrosis].Arch Pediatr. 2004 Apr;11(4):360-6. doi: 10.1016/j.arcped.2003.12.024. Arch Pediatr. 2004. PMID: 15139322 Review. French.
-
Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update.Ann Clin Microbiol Antimicrob. 2019 Feb 4;18(1):7. doi: 10.1186/s12941-019-0306-0. Ann Clin Microbiol Antimicrob. 2019. PMID: 30717798 Free PMC article. Review.
Cited by
-
[Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis].Enferm Infecc Microbiol Clin. 2009 Feb;27(2):89-104. doi: 10.1016/j.eimc.2008.05.004. Epub 2009 Feb 20. Enferm Infecc Microbiol Clin. 2009. PMID: 19232782 Free PMC article. Review. Spanish.
-
Specific biomarker mining and rapid detection of Burkholderia cepacia complex by recombinase polymerase amplification.Front Microbiol. 2023 Sep 14;14:1270760. doi: 10.3389/fmicb.2023.1270760. eCollection 2023. Front Microbiol. 2023. PMID: 37779692 Free PMC article.
-
Phenotypic diversity and genotypic flexibility of Burkholderia cenocepacia during long-term chronic infection of cystic fibrosis lungs.Genome Res. 2017 Apr;27(4):650-662. doi: 10.1101/gr.213363.116. Epub 2017 Mar 21. Genome Res. 2017. PMID: 28325850 Free PMC article.
-
Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products.Clin Microbiol Rev. 2020 Apr 15;33(3):e00139-19. doi: 10.1128/CMR.00139-19. Print 2020 Jun 17. Clin Microbiol Rev. 2020. PMID: 32295766 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous